Effect of breast conservation therapy vs mastectomy on disease-specific survival for early-stage breast cancer

JAMA Surgery

Volumn 149, Issue 3, 2014, Pages 267-274

  Agarwal, Shailesh ^a   Pappas, Lisa ^b   Neumayer, Leigh ^c   Kokeny, Kristine ^c   Agarwal, Jayant ^c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST CONSERVATION THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; DISEASE SPECIFIC SURVIVAL; EPIDEMIOLOGY; FEMALE; HAZARD ASSESSMENT; HAZARD RATIO; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MASTECTOMY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROPENSITY SCORE; STRATIFICATION; SURVIVAL RATE; TUMOR VOLUME;

ADULT; AGED; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MASTECTOMY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; SEER PROGRAM; SURVIVAL ANALYSIS;

EID: 84897866759     PISSN: 21686254     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamasurg.2013.3049     Document Type: Article

References (18)

1. NIH Consensus Development Conference statement on the treatment of early-stage breast cancer. Oncology (Williston Park). 1991;5(2):120-124.
2. Lee MC, Rogers K, Griffith K, et al. Determinants of breast conservation rates: reasons for mastectomy at a comprehensive cancer center. Breast J. 2009;15(1):34-40.
3. McGuire KP, Santillan AA, Kaur P, et al. Are mastectomies on the rise? a 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients. Ann Surg Oncol. 2009;16(10):2682-2690.
4. Smith GL, Xu Y, Shih YC, et al. Breast-conserving surgery in older patients with invasive breast cancer: current patterns of treatment across the United States. J Am Coll Surg. 2009;209(4):425.e2-433.e2.
5. Lazovich D, Solomon CC, Thomas DB, Moe RE, White E. Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma. Cancer. 1999;86(4):628-637. (Pubitemid 29379408)
6. Blichert-Toft M, Rose C, Andersen JA, et al Danish Breast Cancer Cooperative Group. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. J Natl Cancer Inst Monogr. 1992;(11):19-25.
7. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233-1241. (Pubitemid 35176242)
8. Fisher B, Redmond C, Poisson R, et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1989;320(13):822-828. (Pubitemid 19094701)
9. Jatoi I, Proschan MA. Randomized trials of breast-conserving therapy versus mastectomy for primary breast cancer: a pooled analysis of updated results. Am J Clin Oncol. 2005;28(3):289-294. (Pubitemid 40800482)
10. Lichter AS, Lippman ME, Danforth DN Jr, et al. Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial at the National Cancer Institute. J Clin Oncol. 1992;10(6):976-983.
11. Sarrazin D, Lê MG, Arriagada R, et al. Ten-year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol. 1989;14(3):177-184. (Pubitemid 19087084)
12. van Dongen JA, Bartelink H, Fentiman IS, et al. Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. J Natl Cancer Inst Monogr. 1992;(11):15-18.
13. Veronesi U, Saccozzi R, Del Vecchio M, et al. Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast. N Engl J Med. 1981;305(1):6-11. (Pubitemid 11071189)
14. Surveillance, Epidemiology, and End Results (SEER) Program. SEER program overview. National Cancer Institute website. http://seer.cancer.gov/about/ overview.html. Accessed December 8, 2013.
15. Crowe JP Jr, Gordon NH, Shenk RR, Zollinger RM Jr, Brumberg DJ, Shuck JM. Primary tumor size. Relevance to breast cancer survival. Arch Surg. 1992;127(8):910-915, discussion 915-916.
16. Gobardhan PD, Elias SG, Madsen EV, et al. Prognostic value of lymph node micrometastases in breast cancer: a multicenter cohort study. Ann Surg Oncol. 2011;18(6):1657-1664.
17. Hwang ES, Lichtensztajn DY, Gomez SL, Fowble B, Clarke CA. Survival after lumpectomy and mastectomy for early stage invasive breast cancer: the effect of age and hormone receptor status. Cancer. 2013;119(7):1402-1411.
18. Whelan T, Olivotto I, Ackerman I, et al. NCIC-CTGMA.20: an intergroup trial of regional nodal irradiation in early breast cancer [abstract LBA1003]. J Clin Oncol. 2011;29(suppl).